Literature DB >> 28072774

CAR-T's forge ahead, despite Juno deaths.

Laura DeFrancesco.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28072774     DOI： 10.1038/nbt0117-6b

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  13 in total

Review 1.  Adverse Effects Associated with Clinical Applications of CAR Engineered T Cells.

Authors:  Zohreh Sadat Badieyan; Sayed Shahabuddin Hoseini
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2018-02-09       Impact factor: 4.291

Review 2.  Designing natural and synthetic immune tissues.

Authors:  Emily A Gosselin; Haleigh B Eppler; Jonathan S Bromberg; Christopher M Jewell
Journal:  Nat Mater       Date:  2018-05-21       Impact factor: 43.841

Review 3.  Organ-on-a-Chip for Cancer and Immune Organs Modeling.

Authors:  Wujin Sun; Zhimin Luo; Junmin Lee; Han-Jun Kim; KangJu Lee; Peyton Tebon; Yudi Feng; Mehmet R Dokmeci; Shiladitya Sengupta; Ali Khademhosseini
Journal:  Adv Healthc Mater       Date:  2019-01-03       Impact factor: 9.933

4.  A phase I trial of NK-92 cells for refractory hematological malignancies relapsing after autologous hematopoietic cell transplantation shows safety and evidence of efficacy.

Authors:  Brent A Williams; Arjun Datt Law; Bertrand Routy; Neal denHollander; Vikas Gupta; Xing-Hua Wang; Amélie Chaboureau; Sowmya Viswanathan; Armand Keating
Journal:  Oncotarget       Date:  2017-07-12

5.  Human antibody-based chemically induced dimerizers for cell therapeutic applications.

Authors:  Zachary B Hill; Alexander J Martinko; Duy P Nguyen; James A Wells
Journal:  Nat Chem Biol       Date:  2017-12-04       Impact factor: 15.040

6.  Direct control of CAR T cells through small molecule-regulated antibodies.

Authors:  Spencer Park; Edward Pascua; Kevin C Lindquist; Christopher Kimberlin; Xiaodi Deng; Yvonne S L Mak; Zea Melton; Theodore O Johnson; Regina Lin; Bijan Boldajipour; Robert T Abraham; Jaume Pons; Barbra Johnson Sasu; Thomas J Van Blarcom; Javier Chaparro-Riggers
Journal:  Nat Commun       Date:  2021-01-29       Impact factor: 14.919

Review 7.  Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy.

Authors:  Zhenguang Wang; Weidong Han
Journal:  Biomark Res       Date:  2018-01-22

Review 8.  Clinical development of CAR T cells-challenges and opportunities in translating innovative treatment concepts.

Authors:  Jessica Hartmann; Martina Schüßler-Lenz; Attilio Bondanza; Christian J Buchholz
Journal:  EMBO Mol Med       Date:  2017-09       Impact factor: 12.137

Review 9.  Immune Cell Hacking: Challenges and Clinical Approaches to Create Smarter Generations of Chimeric Antigen Receptor T Cells.

Authors:  Reza Elahi; Elnaz Khosh; Safa Tahmasebi; Abdolreza Esmaeilzadeh
Journal:  Front Immunol       Date:  2018-07-31       Impact factor: 7.561

10.  Rapidly Switchable Universal CAR-T Cells for Treatment of CD123-Positive Leukemia.

Authors:  Simon Loff; Josephine Dietrich; Jan-Erik Meyer; Julia Riewaldt; Johannes Spehr; Malte von Bonin; Cordula Gründer; Mridula Swayampakula; Kristin Franke; Anja Feldmann; Michael Bachmann; Gerhard Ehninger; Armin Ehninger; Marc Cartellieri
Journal:  Mol Ther Oncolytics       Date:  2020-04-29       Impact factor: 7.200
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.